The association of metabolic syndrome and COVID-19 deterioration

Elise Ouedraogo (1, 2) , Lucie Allard (3, 1) , Hélène Bihan (1, 3) , Jeanne Goupil de Bouillé (2, 1) , Bénédicte Giroux-Leprieur (4) , Angela Sutton (1, 5) , Camille Baudry (3, 1) , Constant Josse (6) , Morgane Didier (1) , David Deutsch (7, 1) , Imen Rezgani (3, 1) , Olivier Bouchaud (2, 1) , Emmanuel Cosson (1, 3, 8)

1 Hôpital Avicenne [AP-HP]
2 Service de maladies infectieuses et tropicales [CHU Avicenne]
3 Service d'endocrinologie, diabétologie, maladies métaboliques [Avicenne]
4 Service de médecine interne [Avicenne]
5 LEPS - Laboratoire éducations et promotion de la santé
6 eXYSTAT [Malakoff]
7 Service de Gastro-entérologie [Avicenne]
8 EREN [CRESS - U1153 / UMR_A 1125] - Nutritional Epidemiology Research Team | Equipe de Recherche en Epidémiologie Nutritionnelle

Background and aimsTo evaluate the prevalence and prognostic value of metabolic syndrome (MetS) in patients admitted for coronavirus disease 2019 (COVID-19).Methods and resultsIn this monocentric cohort retrospective study, we consecutively included all adult patients admitted to COVID-19 units between April 9 and May 29, 2020 and between February 1 and March 26, 2021. MetS was defined when at least three of the following components were met: android obesity, high HbA1c, hypertension, hypertriglyceridemia, and low HDL cholesterol. COVID-19 deterioration was defined as the need for nasal oxygen flow ≥6 L/min within 28 days after admission.We included 155 patients (55.5% men, mean age 61.7 years old, mean body mass index 29.8 kg/m2). Fifty-six patients (36.1%) had COVID-19 deterioration. MetS was present in 126 patients (81.3%) and was associated with COVID-19 deterioration (no-MetS vs MetS: 13.7% and 41.2%, respectively, p < 0.01). Logistic regression taking into account MetS, age, gender, ethnicity, period of inclusion, and Charlson Index showed that COVID-19 deterioration was 5.3 times more likely in MetS patients (95% confidence interval 1.3–20.2) than no-MetS patients.ConclusionsOver 81.3% of patients hospitalized in COVID-19 units had MetS. This syndrome appears to be an independent risk factor of COVID-19 deterioration.

Mots clés: COVID-19 deterioration; Metabolic syndrome; Prevalence; Prognosis

Domaines: Alimentation et Nutrition; Cardiologie et système cardiovasculaire; Endocrinologie et métabolisme

Elise Ouedraogo, Lucie Allard, Hélène Bihan, Jeanne Goupil de Bouillé, Bénédicte Giroux-Leprieur, et al.. The association of metabolic syndrome and COVID-19 deterioration. Nutrition, Metabolism and Cardiovascular Diseases, 2021, 31 (11), pp.3236-3242. ⟨10.1016/j.numecd.2021.08.036⟩. ⟨hal-03621240⟩